• Via Ritzau pressemeddelelser
  • Via Ritzau selskabsmeddelelser
  • Globenewswire
  • Business Wire
Autodoc GmbH

Autodoc also sees profitable growth in 2019 and continues its expansion course in Europe4.8.2020 10:00:00 CEST | Autodoc GmbH

Sales target for 2019 achieved: strong organic sales growth of 48% to EUR615m EBITDA reaches EUR44.6m, up 50% Operations expanded to Ireland in June 2020, bringing the total to 27 countries Turnover target of over EUR800m for 2020 BERLIN, 4 August 2020 – Autodoc, Europe's leading online dealer in the automotive aftermarket, also grew profitably in the fiscal year 2019, thus continuing its consistent success story that began in its founding year of 2008.The company was able to significantly increase its sales and turnover of automotive spare parts, consumables and accessories on the internet. Net sales increased by 48% year-on-year to EUR615.0m (2018: EUR415m). As a result, Autodoc achieved its own sales target of over EUR600m. Earnings before interest, taxes, depreciation and amortisation (EBITDA) increased by 50% to EUR44.6m (2018: EUR29.7m). The return on sales improved slightly to 5.0% (2018: 4.8%). Autodoc's customers are end consumers (B2C) and increasingly also corporate customer

Covid-19-patienter kan reddes ved at dæmpe immunsystemet4.8.2020 08:26:19 CEST | Aarhus Universitet Natural Sciences

Immunsystemet beskytter mennesker mod angreb fra udefrakommende fjender som bakterier og virus, men nogle gange bliver kampen mod de ydre fjender så voldsom, at det har døden til følge. Når mennesker rammes af COVID-19, bremser immunsystemet spredning af virus ved at bremse celledeling. Ny forskning viser, at det betyder, at lungerne ikke kan reparere ødelagt væv, hvorfor mange patienter bukker under for sygdommen. En vej til at redde alvorligt syge COVID-19-patienter er derfor at dæmpe immunsystemets kemiske krigsførelse.
  • 1
  • 2
  • 3
  • 4
  • 5
  • Sidste
  • >>